Moreover, IHC and IF demonstrated that TMEM170B was localized in the plasma membrane and cytoplasmic regions of pancreatic cancer cells (Figures 2C,E) and that 63.2% of the pancreatic cancer tissue samples were TMEM170B positive (Figure 2D). This evidence concerns the gene TMEM170B and pancreatic neoplasm.